Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by EUGENE GRYGIELKO
Gene Expression in Rats With Renal Disease Treated With the Angiotensin II Receptor Antagonist, Eprosartan
Physiological Genomics
Genetics
Physiology
Related publications
Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Higher Small Arterial Elasticity in Hypertensive Patients Treated With Angiotensin II Receptor Blockers
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Renal Hemodynamic and Hormonal Responses to the Angiotensin II Antagonist Candesartan
Hypertension
Internal Medicine
Conversion of Renal Angiotensin II to Angiotensin III Is Critical for AT2 Receptor-Mediated Natriuresis in Rats
Hypertension
Internal Medicine
Reduced Sensitivity of the Renal Vasculature to Angiotensin II in Young Rats: The Role of the Angiotensin Type 2 Receptor
Pediatric Research
Child Health
Pediatrics
Perinatology
Genistein Alters Coagulation Gene Expression in Ovariectomised Rats Treated With Phytoestrogens
Thrombosis and Haemostasis
Hematology
Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitor Combined With Α1-Adrenergic Antagonist in Spontaneously Hypertensive Rats With Renal Ablation
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Association of Angiotensin II Type 2 Receptor Gene Variant With Hypertension
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Tacr1 Gene Variation and Neurokinin 1 Receptor Expression Is Associated With Antagonist Efficacy in Genetically Selected Alcohol-Preferring Rats
Biological Psychiatry
Biological Psychiatry
